A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes

European Journal of Clinical Pharmacology

Volumn 34, Issue 2, 1988, Pages 129-132

  McAlpine, L G ^a   McAlpine, C H ^a   Waclawski, E R ^a   Storer, A M ^a   Kay, J W ^b   Frier, B M ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

body weight; diabetes mellitus; metformin; non insulin dependent; sulphonylurea

Indexed keywords

GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

BODY WEIGHT; CLINICAL ARTICLE; CROSSOVER PROCEDURE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHT; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; GLICLAZIDE; HUMAN; INSULIN; LACTATES; MALE; METFORMIN; MIDDLE AGE; SULFONYLUREA COMPOUNDS; SUPPORT, NON-U.S. GOV'T;

EID: 0023946973     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00614548     Document Type: Article

References (10)

1. Comparison of chlorpropamide and metformin treatment on weight and blood glucose response of uncontrolled obese diabetics
2. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet
3. UK prospective studies of therapies of maturity-onset diabetes. 1. Effect of diet, sulphonylureas, insulin or biguanide therapy on fasting plasma glucose and body weight over 1 year
4. Home blood glucose monitoring in non-insulin-dependent diabetics; the effect of gliclazide on blood glucose and weight control
5. Insulin and glucagon secretion from isolated islets of Langerhans: The effects of calcium ionophores
6. Some statistical methods useful in circulation research
7. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus
8. Metformin kinetics in healthy subjects and in patients with diabetes mellitus
9. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity onset diabetes